MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a number one developer of high-quality, extremely correct sequencing platforms, at present introduced a analysis collaboration with Google. Under the phrases of the collaboration, PacBio will discover the usage of Google’s genomic evaluation, machine studying and algorithm growth instruments to additional enhance PacBio’s already extremely correct variant requires HiFi sequencing runs, unlocking extra insights from PacBio sequencing information. The collaboration builds on earlier analysis from PacBio and Google. A current publication on the work out there on bioRxiv, Deep Consensus: Gap-Aware Sequence Transformers for Sequence Correction, yielded enhancements in variant calling and prompt that Google’s DeepConsensus machine studying software is able to growing the yield of 99.9 % correct HiFi reads by as a lot as one other 27 % per instrument run. “By collaborating with Google, PacBio will finally assist our clients additional enhance the standard and output of HiFi information by decreasing the variety of sequencing passes wanted to obtain excessive confidence in base accuracy,” mentioned Christian Henry, President and CEO of PacBio. “These enhancements in accuracy and information evaluation have the potential to allow extra clients to expertise the advantages of long-read sequencing as a part of their analysis and translational initiatives, finally making a optimistic affect on implementing genomics in precision well being.” PacBio hopes to enhance the utility and general worth of HiFi information particularly for purposes reminiscent of complete genome sequencing (WGS), full-length isoform, and focused sequencing purposes by integrating Google’s deep studying know-how into its future product releases. “Collaborating with PacBio presents the chance to assist unlock extra of the worth in extremely correct genomic information, which can allow the analysis group to additional enhance their understanding of biology,” mentioned Andrew Carroll, Genomics Product Lead for Health AI at Google. “This is a robust step ahead in working with the genomics group to maximize the worth of genomic information.” Terms of the deal weren’t disclosed. To study extra about HiFi sequencing, go to www.pacb.com/HiFi. About PacBioPacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with extremely correct sequencing platforms. The firm’s modern devices are based mostly on Single Molecule, Real-Time (SMRT®) Sequencing know-how, which delivers a complete view of genomes, transcriptomes, and epigenomes, enabling entry to the total spectrum of genetic variation in any organism. Cited in hundreds of peer-reviewed publications, PacBio® sequencing techniques are in use by scientists world wide to drive discovery in human biomedical analysis, plant and animal sciences, and microbiology. For extra info, please go to www.pacb.com and comply with @PacBio. PacBio merchandise are offered for Research Use Only. Not to be used in diagnostic procedures. Forward-Looking Statements This press launch might include “forward-looking statements” throughout the which means of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995, together with statements relating to future availability, launch dates, makes use of, accuracy, benefits, high quality or efficiency of, or advantages or anticipated advantages of utilizing, PacBio merchandise or applied sciences, the suitability or utility of such merchandise or applied sciences for explicit purposes or initiatives, together with in reference to the usage of genomic evaluation machine studying and algorithm growth instruments to discover enhancements to variant calling accuracy; and different future occasions. You mustn’t place undue reliance on forward-looking statements as a result of they contain recognized and unknown dangers, uncertainties, adjustments in circumstances and different components which can be, in some instances, past PacBio’s management and might trigger precise outcomes to differ materially from the knowledge expressed or implied by forward-looking statements made on this press launch. Factors that would materially have an effect on precise outcomes could be present in PacBio’s most up-to-date filings with the Securities and Exchange Commission, together with PacBio’s most up-to-date studies on Forms 8-Ok, 10-Ok, and 10-Q, and embody these listed underneath the caption “Risk Factors.” PacBio undertakes no obligation to revise or replace info on this press launch to replicate occasions or circumstances sooner or later, even when new info turns into out there. ContactsInvestors:Todd [email protected] Media:Kathy [email protected]
https://www.globenewswire.com/news-release/2022/01/11/2364709/0/en/PacBio-and-Google-Collaborate-to-Use-Machine-Learning-to-Optimize-Long-Read-Sequencing-Data-Analysis.html
